The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
202
1. Experimental Maintenance treatment with daily medication 2. Experimental Maintenance treatment with thrice-weekly medication
APT Residential Services Division
New Haven, Connecticut, United States
Opioid and cocaine use
Time frame: 26 weeks
Social and psychological functioning
Time frame: 26 weeks
AIDS risk behavior
Time frame: 26 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.